Population
Patients with acute heart failure syndromes, ischemic heart disease, cardiogenic or septic shock, and those…
Design
Review
Authors
Loading...
May inform levosimendan selection in acute HF or shock; leaves open RCTs confirming ischemic cardioprotection.
Levosimendan improves myocardial function without increasing oxygen consumption, offering potential benefits in acute heart failure, shock, and perioperative cardiac surgery.
Nieminen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: